India Alzheimer's Therapeutic Market Research Report 2018

Publisher Name :
Date: 16-May-2018
No. of pages: 113
Inquire Before Buying

The global Alzheimer's Therapeutic market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

India plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Alzheimer's Therapeutic development status and future trend in India, focuses on top players in India, also splits Alzheimer's Therapeutic by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in India market include

- Pfizer Inc

- Novartis International AG

- Axovant Sciences Ltd

- Acadia Pharmaceuticals, Inc

- Biotie Therapies

- Astra Zeneca plc

- Eli Lilly, Inc

- F. Hoffman Le Roche

- Merck & Co

- H. Lundbeck A/S

- Takeda Pharmaceutical Company Ltd

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

- Memantine Hydrochloride

- Donepezil Hydrochloride

- Rivastigmine

- Galantamine Hydrobromide

On the basis of the end users/Application, this report covers

- Hospitals

- Clinic

- Other

If you have any special requirements, please let us know and we will offer you the report as you want.

India Alzheimer's Therapeutic Market Research Report 2018

Table of Contents
India Alzheimer's Therapeutic Market Research Report 2018
1 Alzheimer's Therapeutic Overview
1.1 Product Overview and Scope of Alzheimer's Therapeutic
1.2 Classification of Alzheimer's Therapeutic by Product Category
1.2.1 India Alzheimer's Therapeutic Sales (K Pcs) Comparison by Type (2013-2025)
1.2.2 India Alzheimer's Therapeutic Sales (K Pcs) Market Share by Type in 2017
1.2.3 Memantine Hydrochloride
1.2.4 Donepezil Hydrochloride
1.2.5 Rivastigmine
1.2.6 Galantamine Hydrobromide
1.3 India Alzheimer's Therapeutic Market by Application/End Users
1.3.1 India Alzheimer's Therapeutic Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 India Revenue and Sales of Alzheimer's Therapeutic (2013-2025)
1.4.1 India Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2025)
1.4.2 India Alzheimer's Therapeutic Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 India Alzheimer's Therapeutic Market Competition by Players/Manufacturers
2.1 India Alzheimer's Therapeutic Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 India Alzheimer's Therapeutic Revenue and Share by Players/Manufacturers (2013-2018)
2.3 India Alzheimer's Therapeutic Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 India Alzheimer's Therapeutic Market Competitive Situation and Trends
2.4.1 India Alzheimer's Therapeutic Market Concentration Rate
2.4.2 India Alzheimer's Therapeutic Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in India Market
2.5 India Players/Manufacturers Alzheimer's Therapeutic Manufacturing Base Distribution, Sales Area, Product Type
3 India Alzheimer's Therapeutic Sales and Revenue (Value) by Type (2013-2018)
3.1 India Alzheimer's Therapeutic Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 India Alzheimer's Therapeutic Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 India Alzheimer's Therapeutic Price (USD/Pcs) by Type (2013-2018)
3.4 India Alzheimer's Therapeutic Sales Growth Rate (%) by Type (2013-2018)
4 India Alzheimer's Therapeutic Sales by Application (2013-2018)
4.1 India Alzheimer's Therapeutic Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 India Alzheimer's Therapeutic Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities
5 India Alzheimer's Therapeutic Players/Suppliers Profiles and Sales Data
5.1 Pfizer Inc
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 Pfizer Inc Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 Novartis International AG
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 Novartis International AG Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Axovant Sciences Ltd
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Axovant Sciences Ltd Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 Acadia Pharmaceuticals, Inc
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 Acadia Pharmaceuticals, Inc Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 Biotie Therapies
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 Biotie Therapies Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 Astra Zeneca plc
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 Astra Zeneca plc Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
5.7 Eli Lilly, Inc
5.7.1 Company Basic Information, Manufacturing Base and Competitors
5.7.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.7.2.1 Product A
5.7.2.2 Product B
5.7.3 Eli Lilly, Inc Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.7.4 Main Business/Business Overview
5.8 F. Hoffman Le Roche
5.8.1 Company Basic Information, Manufacturing Base and Competitors
5.8.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.8.2.1 Product A
5.8.2.2 Product B
5.8.3 F. Hoffman Le Roche Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.8.4 Main Business/Business Overview
5.9 Merck & Co
5.9.1 Company Basic Information, Manufacturing Base and Competitors
5.9.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.9.2.1 Product A
5.9.2.2 Product B
5.9.3 Merck & Co Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.9.4 Main Business/Business Overview
5.10 H. Lundbeck A/S
5.10.1 Company Basic Information, Manufacturing Base and Competitors
5.10.2 Alzheimer's Therapeutic Product Category, Application and Specification
5.10.2.1 Product A
5.10.2.2 Product B
5.10.3 H. Lundbeck A/S Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.10.4 Main Business/Business Overview
5.11 Takeda Pharmaceutical Company Ltd
6 Alzheimer's Therapeutic Manufacturing Cost Analysis
6.1 Alzheimer's Therapeutic Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Alzheimer's Therapeutic
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Alzheimer's Therapeutic Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Alzheimer's Therapeutic Major Manufacturers in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 India Alzheimer's Therapeutic Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 India Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 India Alzheimer's Therapeutic Sales (K Pcs) Forecast by Type (2018-2025)
10.3 India Alzheimer's Therapeutic Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Figure India Market Size (Million USD) Status and Outlook (2013-2025)
Table Alzheimer's Therapeutic Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Alzheimer's Therapeutic Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of Alzheimer's Therapeutic
Table India Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure India Alzheimer's Therapeutic Sales Volume Market Share by Type in 2017
Figure Memantine Hydrochloride Product Picture
Figure Donepezil Hydrochloride Product Picture
Figure Rivastigmine Product Picture
Figure Galantamine Hydrobromide Product Picture
Figure India Alzheimer's Therapeutic Sales (K Pcs) Comparison by Application (2013-2025)
Figure India Sales Market Share (%) of Alzheimer's Therapeutic by Application in 2017
Figure Hospitals Examples
Figure Clinic Examples
Figure Other Examples
Figure India Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure India Alzheimer's Therapeutic Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table India Alzheimer's Therapeutic Sales of Key Players/Manufacturers (2013-2018)
Table India Alzheimer's Therapeutic Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 India Alzheimer's Therapeutic Sales Share (%) by Players/Manufacturers
Figure 2017 India Alzheimer's Therapeutic Sales Share (%) by Players/Manufacturers
Table India Alzheimer's Therapeutic Revenue by Players/Manufacturers (2013-2018)
Table India Alzheimer's Therapeutic Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 India Alzheimer's Therapeutic Revenue Share (%) by Players/Manufacturers
Figure 2017 India Alzheimer's Therapeutic Revenue Share (%) by Players/Manufacturers
Table India Market Alzheimer's Therapeutic Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure India Market Alzheimer's Therapeutic Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure India Alzheimer's Therapeutic Market Share of Top 3 Players/Manufacturers
Figure India Alzheimer's Therapeutic Market Share of Top 5 Players/Manufacturers
Table India Players/Manufacturers Alzheimer's Therapeutic Manufacturing Base Distribution and Sales Area
Table India Players/Manufacturers Alzheimer's Therapeutic Product Category
Table India Alzheimer's Therapeutic Sales (K Pcs) by Type (2013-2018)
Table India Alzheimer's Therapeutic Sales Share (%) by Type (2013-2018)
Figure India Alzheimer's Therapeutic Sales Share (%) by Type (2013-2018)
Figure India Alzheimer's Therapeutic Sales Market Share (%) by Type in 2017
Table India Alzheimer's Therapeutic Revenue (Million USD) and Market Share by Type (2013-2018)
Table India Alzheimer's Therapeutic Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Alzheimer's Therapeutic by Type (2013-2018)
Figure Revenue Market Share of Alzheimer's Therapeutic by Type in 2017
Table India Alzheimer's Therapeutic Price (USD/Pcs) by Type (2013-2018)
Figure India Alzheimer's Therapeutic Sales Growth Rate (%) by Type (2013-2018)
Table India Alzheimer's Therapeutic Sales (K Pcs) by Application (2013-2018)
Table India Alzheimer's Therapeutic Sales Market Share (%) by Application (2013-2018)
Figure India Alzheimer's Therapeutic Sales Market Share (%) by Application (2013-2018)
Figure India Alzheimer's Therapeutic Sales Market Share (%) by Application in 2017
Table India Alzheimer's Therapeutic Sales Growth Rate (%) by Application (2013-2018)
Figure India Alzheimer's Therapeutic Sales Growth Rate (%) by Application (2013-2018)
Table Pfizer Inc Alzheimer's Therapeutic Basic Information List
Table Pfizer Inc Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Pfizer Inc Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Pfizer Inc Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure Pfizer Inc Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table Novartis International AG Alzheimer's Therapeutic Basic Information List
Table Novartis International AG Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Novartis International AG Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Novartis International AG Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure Novartis International AG Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table Axovant Sciences Ltd Alzheimer's Therapeutic Basic Information List
Table Axovant Sciences Ltd Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Axovant Sciences Ltd Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Axovant Sciences Ltd Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure Axovant Sciences Ltd Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table Acadia Pharmaceuticals, Inc Alzheimer's Therapeutic Basic Information List
Table Acadia Pharmaceuticals, Inc Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Acadia Pharmaceuticals, Inc Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Acadia Pharmaceuticals, Inc Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure Acadia Pharmaceuticals, Inc Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table Biotie Therapies Alzheimer's Therapeutic Basic Information List
Table Biotie Therapies Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Biotie Therapies Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Biotie Therapies Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure Biotie Therapies Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table Astra Zeneca plc Alzheimer's Therapeutic Basic Information List
Table Astra Zeneca plc Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Astra Zeneca plc Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Astra Zeneca plc Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure Astra Zeneca plc Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table Eli Lilly, Inc Alzheimer's Therapeutic Basic Information List
Table Eli Lilly, Inc Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Eli Lilly, Inc Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Eli Lilly, Inc Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure Eli Lilly, Inc Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table F. Hoffman Le Roche Alzheimer's Therapeutic Basic Information List
Table F. Hoffman Le Roche Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure F. Hoffman Le Roche Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure F. Hoffman Le Roche Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure F. Hoffman Le Roche Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table Merck & Co Alzheimer's Therapeutic Basic Information List
Table Merck & Co Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Merck & Co Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Merck & Co Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure Merck & Co Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table H. Lundbeck A/S Alzheimer's Therapeutic Basic Information List
Table H. Lundbeck A/S Alzheimer's Therapeutic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure H. Lundbeck A/S Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure H. Lundbeck A/S Alzheimer's Therapeutic Sales Market Share (%) in India (2013-2018)
Figure H. Lundbeck A/S Alzheimer's Therapeutic Revenue Market Share (%) in India (2013-2018)
Table Takeda Pharmaceutical Company Ltd Alzheimer's Therapeutic Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer's Therapeutic
Figure Manufacturing Process Analysis of Alzheimer's Therapeutic
Figure Alzheimer's Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer's Therapeutic Major Players/Manufacturers in 2017
Table Major Buyers of Alzheimer's Therapeutic
Table Distributors/Traders List
Figure India Alzheimer's Therapeutic Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure India Alzheimer's Therapeutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Alzheimer's Therapeutic Price (USD/Pcs) Trend Forecast (2018-2025)
Table India Alzheimer's Therapeutic Sales (K Pcs) Forecast by Type (2018-2025)
Figure India Alzheimer's Therapeutic Sales (K Pcs) Forecast by Type (2018-2025)
Figure India Alzheimer's Therapeutic Sales Volume Market Share Forecast by Type in 2025
Table India Alzheimer's Therapeutic Sales (K Pcs) Forecast by Application (2018-2025)
Figure India Alzheimer's Therapeutic Sales Volume Market Share Forecast by Application (2018-2025)
Figure India Alzheimer's Therapeutic Sales Volume Market Share Forecast by Application in 2025
  • Global Anti-infective Ophthalmic Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 122
    Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals. Scope of the Report: This report focuses on the Anti-infective Ophthal......
  • Global Cannabis Oil Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 124
    Cannabis oil is from the marijuana plant (cannabis indicas). The oil is extracted from the leaves of the cannabis plant. It contains high levels of THC. It is used for medicinal purposes and as a recreational drug. Cannabis oil reached considerable popularity when a man in Canada named Rick Simpson began distributing this concentrate, albeit illegally, as a medicine. Rick's oil (commonly known as "Rick Simpson oil") brought the long studied knowledge about the anti-tumor and various medi......
  • Global Darbepoetin Alfa Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 124
    Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and ......
  • Global Hemostasis and Tissue Sealing Agents Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 136
    Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing. Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operati......
  • Global Humira Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 121
    Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa. Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis. ......
  • Global Hypromellose Acetate Succinate Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 119
    Hypromellose acetate succinate is an enteric coating material which was first approved in Japan in 1987. As of January 2004, this product has been approved in Korea, several countries in Europe, and USA as well as in Japan. Scope of the Report: This report focuses on the Hypromellose Acetate Succinate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manuf......
  • Global IGY Polyclonal Antibodies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 120
    Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them. IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation proces......
  • Global Platinum based Cancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 122
    Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development. Scope of the Report: This report focuses on the Platinum based Cancer Drug......
  • Global Hepatocyte Growth Factor Market Professional Survey Report 2018
    Published: 20-Aug-2018        Price: US 3500 Onwards        Pages: 104
    This report studies the global Hepatocyte Growth Factor market status and forecast, categorizes the global Hepatocyte Growth Factor market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs